Free Trial
OTCMKTS:KIADF

Kiadis Pharma (KIADF) Stock Price, News & Analysis

Kiadis Pharma logo
$6.41 0.00 (0.00%)
As of 07/21/2021

About Kiadis Pharma Stock (OTCMKTS:KIADF)

Key Stats

Today's Range
$6.41
$6.41
50-Day Range
$6.41
$6.41
52-Week Range
$1.72
$6.55
Volume
N/A
Average Volume
1,800 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kiadis Pharma N.V., a biopharmaceutical company, develops cell-based immunotherapy products in the field of blood building system. The company develops K-NK002 as an adjunctive immunotherapeutic, which is in Phase II clinical trials for blood cancer patients undergoing a haploidentical HSCT with the post-transplant cyclophosphamide (PTCy) protocol; and K-NK003, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia relapse/refractory (AML R/R). The company's preclinical stage product include K-NK00X, a NK-cell therapy candidate for the treatment of various solid tumors. It has a collaboration agreement with Harbour BioMed, Utrecht University, Erasmus Medical Center, and Viroclinics-DDL for the development of a combination of a monoclonal antibody and natural killer cells as a treatment for COVID-19. Kiadis Pharma N.V. was founded in 1997 and is headquartered in Amsterdam, the Netherlands.

Receive KIADF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiadis Pharma and its competitors with MarketBeat's FREE daily newsletter.

KIADF Stock News Headlines

Ascendis Pharma Announces FDA Approval Of YORVIPATH - Quick Facts
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
LTRN Lantern Pharma Inc.
Alnylam Pharmaceuticals
The Best Kids Luggage: 9 Picks for 2023
See More Headlines

KIADF Stock Analysis - Frequently Asked Questions

Kiadis Pharma's stock was trading at $6.41 at the beginning of the year. Since then, KIADF stock has increased by 0.0% and is now trading at $6.41.
View the best growth stocks for 2025 here
.

Shares of KIADF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:KIADF
CIK
N/A
Fax
N/A
Employees
103
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:KIADF) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners